Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

International Business Machines (IBM)

2026-02-24T17:17:00.665157+00:00

Executive Summary

IBM shares rebounded 3.58% to $231.34 following a catastrophic 13.1% single-day decline triggered by Anthropic's Claude AI announcement targeting IBM's legacy mainframe business. While this technical bounce provides temporary relief, the stock remains down 21.90% year-to-date and faces its worst monthly performance in 34 years, with the fundamental investment thesis now under severe pressure from AI-driven disruption to core revenue streams.

Key Updates

The 3.58% recovery represents a technical bounce following extreme oversold conditions rather than fundamental improvement. The catalyst for the previous session's 13.1% collapse was Anthropic's announcement of Claude AI's code modernization capabilities for legacy COBOL applications, which investors view as directly threatening IBM's mainframe business. Additional headwinds emerged from President Trump's announcement of 15% tariffs on all imports, prompting the EU and India to suspend trade negotiations. IBM is experiencing its worst monthly performance in 34 years, with the stock declining over 20% in February alone.

Current Trend

IBM has deteriorated sharply from $223.35 in the previous report to a current level of $231.34, though this represents only a modest technical recovery following extreme selling pressure. The year-to-date decline of 21.90% marks a dramatic reversal from the company's recent success story. The 1-month decline of 20.89% and 5-day decline of 10.44% despite today's bounce illustrate the severity of the market's reassessment of IBM's business model. The stock has broken through multiple support levels and is trading at its lowest valuation in years relative to the broader market. The 6-month decline of 4.44% shows deterioration accelerated dramatically in February 2026.

Investment Thesis

The investment thesis centered on IBM's successful transformation into an AI and hybrid cloud leader is now under fundamental challenge. The core assumption that IBM's mainframe business would remain protected while the company scaled its watsonx AI platform and consulting services has been disrupted by competitive AI technologies targeting legacy code modernization. The thesis relied on three pillars: hybrid cloud orchestration through Red Hat, enterprise-focused AI models via Granite/watsonx, and high-margin consulting services. The emergence of AI tools capable of modernizing COBOL applications directly threatens the economic moat around IBM's mainframe installed base, which has historically provided stable, high-margin recurring revenue. The tariff environment adds macroeconomic pressure to enterprise IT spending decisions.

Thesis Status

The investment thesis has shifted from intact to materially challenged. While IBM's Q4 2025 results demonstrated 8% revenue growth and the company secured over $10 billion in generative AI consulting contracts, the Anthropic Claude announcement has created existential concerns about IBM's mainframe business. The market is repricing IBM's valuation multiples downward from software-leader levels back toward legacy technology company levels. The strategic initiatives remain sound—autonomous storage with agentic AI, tripling Gen Z hiring for AI-fluent workforce, and expanding partner ecosystem—but the timeline for AI revenue to offset potential mainframe erosion has compressed dramatically. The 15% tariff announcement creates additional uncertainty for global enterprise IT budgets, potentially delaying transformation projects that drive IBM's consulting revenue.

Key Drivers

Immediate Catalyst: Anthropic's Claude AI code modernization capabilities triggered a 13.1% decline as investors reassessed the durability of IBM's mainframe franchise. The technology enables automated conversion of legacy COBOL applications, potentially accelerating customer migration away from IBM mainframes.

Macroeconomic Pressure: President Trump's announcement of 15% tariffs on all imports prompted the EU and India to suspend trade negotiations, creating uncertainty for multinational IT spending and IBM's global consulting business.

Product Innovation: IBM introduced autonomous storage with its FlashSystem portfolio powered by agentic AI, demonstrating continued innovation in enterprise infrastructure, though this announcement was overshadowed by competitive threats.

Workforce Strategy: IBM is tripling Gen Z entry-level hiring, redesigning roles to emphasize AI fluency and positioning for long-term talent advantage, contrasting with industry trends toward AI-driven workforce reduction.

Government Contracts: IBM secured Missile Defense Agency SHIELD contract support and partnered with Contiem for UK Ministry of Defence AI-powered logistics upgrades, providing stable government revenue streams.

Technical Analysis

IBM is attempting to stabilize following a capitulation-style selloff that erased months of gains. The 3.58% bounce from $223.35 to $231.34 represents a minor technical recovery but lacks conviction given the 21.90% YTD decline. The stock broke below the psychologically important $230 level during the selloff and is now testing this level as resistance. Volume patterns suggest institutional distribution rather than accumulation. The 1-month chart shows a breakdown from a consolidation pattern near $290, with the stock falling through multiple support levels without meaningful bounces. The 5-day decline of 10.44% despite today's gain indicates selling pressure remains elevated. Key resistance now sits at $240-245, while support has been established tentatively at $220-223. The relative strength versus the broader market has deteriorated significantly, with IBM underperforming technology peers by substantial margins. The technical setup suggests a potential dead-cat bounce rather than a sustainable reversal without fundamental catalysts to restore confidence.

Bull Case

Bear Case

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.